The expression of miRNA-324-3p was down-regulated in patients with KRAS-variant endometrial tumors [33], and miRNA-324-3p was suggested as a prognostic biomarker of endometrial cancer [34]. This evidence concerns the gene KRAS and endometrial cancer.